Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(13 sites)
United States
University of California San Diego NAFLD Research Center, La Jolla, California Keck Medical Center of USC, Los Angeles, California LAC + USC Medical Center, Los Angeles, California UCSF/Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, California UCSF Medical Center, San Francisco, California University of Miami Health System, Miami, Florida University of Michigan, Ann Arbor, Michigan Mayo Clinic, Rochester, Minnesota New York Presbyterian/Weill Cornell, New York, New York Columbia University Iriving School of Medicine, New York, New York Duke Liver Center, Durham, North Carolina Cleveland Clinic, Cleveland, Ohio Virginia Commonwealth University, Richmond, Virginia Age range
18 Years – 75 Years
Last updated January 2026